International Journal of Molecular Imaging / 2013 / Article / Tab 1

Research Article

Cholinergic Depletion in Alzheimer’s Disease Shown by [18F]FEOBV Autoradiography

Table 1

Subject data for AD patients and controls. There is no significant group difference between controls and AD patients for gender distribution, age, or postmortem delay.

GroupSexAgePMD (h)Brain wt (g)ApoE status

ADM679614103-3
ADM9213.2512003-3
ADM668.510754-3
ADM6710.512353-3
ADF7711.258553-3
ADM762410054-3
ADF741810803-3
ADM7326.2511203-3
ADM632112003-3
ADF8824.59553-3
ADM7919.25N/A4-3
ADM7912.7511353-3
ADM7924.7512103-3
ControlM592916503-3
ControlM607.2513503-3
ControlM6528.514353-3
ControlF741113653-3
ControlM717612504-3
ControlM6724.7513004-3
ControlM792213503-3
ControlM7032.7513203-3
ControlF9025.510503-3
ControlM916.7510703-3
ControlM6818.514454-3
ControlM801313053-3
ControlF9126.510003-3
ControlF7917.7511503-3
ControlF9523.7511603-3
ControlM8526.7511853-3
ControlM88811503-3
ControlF5126.251336.13-3
ControlM618.751337.33-3
ControlM5917.671442.53-3
AVG  
(AD)
77%    Male75.3823.851123.3323%    “4-3”
AVG  
(Controls)
70%    Male74.1522.521282.5515%    “4-3”

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.